Form 4: Veracyte SVP Sells Shares Under 10b5-1 Plan

Veracyte's SVP, General Counsel, Annie McGuire, sold 2,283 shares of common stock for a weighted average price of $33.6923 per share pursuant to a pre-arranged 10b5-1 plan.

Summary

• Annie McGuire, SVP, General Counsel of Veracyte, Inc. (VCYT), reported a sale of common stock.
• The transaction involved 2,283 shares of VCYT common stock.
• The shares were sold at a weighted average price of $33.6923 per share, with individual sale prices ranging from $33.50 to $34.00.
• The sale was executed on September 19, 2025.
• Following this transaction, Annie McGuire beneficially owns 91,599 shares of Veracyte common stock directly.
• The transaction was made pursuant to a Rule 10b5-1 plan adopted by Ms. McGuire on September 4, 2024.

Sentiment

Score: 5

Explanation: The sale of shares by an insider, particularly when conducted under a pre-arranged Rule 10b5-1 plan, is generally considered a neutral event. These plans are often established for personal financial planning purposes and do not necessarily reflect a change in the insider's outlook on the company's prospects. The transaction size is also not exceptionally large relative to the company's market capitalization or the insider's remaining holdings.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Minimal impact. A routine insider sale under a 10b5-1 plan is unlikely to significantly affect shareholder confidence or the stock price.
• Employees, Customers, Suppliers, Creditors: No direct impact from this filing.

Key Dates

Keywords

Veracyte, VCYT, Insider Trading, Form 4, Stock Sale, Annie McGuire, 10b5-1 Plan, Corporate Officer